[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR3047641B1 - Formulation comprenant un support d'aerosolisation et de la nicotine r - Google Patents

Formulation comprenant un support d'aerosolisation et de la nicotine r Download PDF

Info

Publication number
FR3047641B1
FR3047641B1 FR1651181A FR1651181A FR3047641B1 FR 3047641 B1 FR3047641 B1 FR 3047641B1 FR 1651181 A FR1651181 A FR 1651181A FR 1651181 A FR1651181 A FR 1651181A FR 3047641 B1 FR3047641 B1 FR 3047641B1
Authority
FR
France
Prior art keywords
nicotine
aerosolisation
support
formulation including
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1651181A
Other languages
English (en)
Other versions
FR3047641A1 (fr
Inventor
Vincent Bonnarme
Antoine Piccirilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRES CERES
Original Assignee
LABORATOIRES CERES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATOIRES CERES filed Critical LABORATOIRES CERES
Priority to FR1651181A priority Critical patent/FR3047641B1/fr
Publication of FR3047641A1 publication Critical patent/FR3047641A1/fr
Application granted granted Critical
Publication of FR3047641B1 publication Critical patent/FR3047641B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une formulation comprenant : - un support d'aérosolisation ; - de la nicotine ; caractérisée en ce qu'au moins 5 % de ladite nicotine est sous forme d'énantiomère R. [0002] Dans un mode de réalisation, la formulation selon l'invention est caractérisée en ce qu'au moins 10 % de ladite nicotine est sous forme d'énantiomère R.
FR1651181A 2016-02-12 2016-02-12 Formulation comprenant un support d'aerosolisation et de la nicotine r Active FR3047641B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1651181A FR3047641B1 (fr) 2016-02-12 2016-02-12 Formulation comprenant un support d'aerosolisation et de la nicotine r

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1651181A FR3047641B1 (fr) 2016-02-12 2016-02-12 Formulation comprenant un support d'aerosolisation et de la nicotine r

Publications (2)

Publication Number Publication Date
FR3047641A1 FR3047641A1 (fr) 2017-08-18
FR3047641B1 true FR3047641B1 (fr) 2021-10-29

Family

ID=56801618

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1651181A Active FR3047641B1 (fr) 2016-02-12 2016-02-12 Formulation comprenant un support d'aerosolisation et de la nicotine r

Country Status (1)

Country Link
FR (1) FR3047641B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700106031A1 (it) * 2017-09-22 2019-03-22 Renzo Luciano Cattaneo Realizzazione di una formulazione liquida per l'addizione rapida di nicotina e la riduzione delle emissione nocive dei liquidi per sigarette elettroniche
CN110506978A (zh) * 2019-09-11 2019-11-29 深圳多客技术有限公司 一种电子烟烟油溶剂、包含其的电子烟烟油及制备方法
CN110916241A (zh) * 2019-11-20 2020-03-27 许达勇 一种烟碱气雾剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56113286A (en) * 1980-02-08 1981-09-07 Japan Tobacco & Salt Public Tobacco smoking taste imparting method
JPS5832878B2 (ja) * 1981-10-26 1983-07-15 日本たばこ産業株式会社 Ｒ−ニコチンの製造法
AU4146985A (en) * 1985-04-22 1986-10-30 Advanced Tobacco Products Inc. Vaporisable nicotine composition
US4793366A (en) * 1985-11-12 1988-12-27 Hill Ira D Nicotine dispensing device and methods of making the same
US4830028A (en) * 1987-02-10 1989-05-16 R. J. Reynolds Tobacco Company Salts provided from nicotine and organic acid as cigarette additives
EP3871515A1 (fr) * 2014-05-27 2021-09-01 R. J. Reynolds Tobacco Company Sels de nicotine, co-cristaux et complexes de co-cristaux de sel

Also Published As

Publication number Publication date
FR3047641A1 (fr) 2017-08-18

Similar Documents

Publication Publication Date Title
USD831558S1 (en) Front face of a vehicle wheel
USD834483S1 (en) Automotive wheel
USD754048S1 (en) Front face of a vehicle wheel
AU2016343803A8 (en) Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
USD845859S1 (en) Vehicle wheel front race
FR3041252B1 (fr) Dispersions stables de gouttes comprenant un agent gelifiant
WO2016164675A8 (fr) Composés quinazoline substitués et leurs procédés d'utilisation
MA38289A1 (fr) Composition pharmaceutique à biodisponibilité ameliorée
WO2016149401A3 (fr) Carbamates de pipérazine et procédés de préparation et d'utilisation de ceux-ci
WO2014076569A3 (fr) Formulations de testostérone topiques à libération commandée et procédés associés
WO2017040335A3 (fr) Complexes de transfection et leurs procédés d'utilisation
CA3010829A1 (fr) Compositions de gel pour administration transdermique permettant de maximiser la concentration de medicaments au niveau du stratum corneum et du serum, et methodes d'utilisation de ces dernieres
SG10201908628QA (en) A stent assembly and method of preparing the stent assembly
FR3047641B1 (fr) Formulation comprenant un support d'aerosolisation et de la nicotine r
MA37445B1 (fr) Lyophilisation d'agent tensioactif pulmonaire liposomal synthétique
PH12014501866A1 (en) Thermosensitive nanoparticle formulations and method of making the same
EA201890367A1 (ru) Композиции и способы для лиофильных форм наночастиц
MX2019004859A (es) Tratamientos de combinacion que comprenden la administracion de imidazopirazinonas.
USD844963S1 (en) Shoe upper
EP4293116A3 (fr) Fibrinogène liquide stable
WO2015173427A3 (fr) Composition a action rapide d'insuline comprenant un compose anionique substitue et un compose polyanionique
EP3620457A4 (fr) Composé dérivé de pyrimidine, isomère optique, ou sel pharmaceutiquement acceptable de celui-ci, et composition pour prévenir ou traiter une maladie liée au tyro 3 le comprenant en tant que principe actif
EA201890212A1 (ru) Новое применение сульфата декстрана
USD754781S1 (en) Sunglasses
WO2014204854A8 (fr) Compositions et procédés utilisables en vue de la préparation d'agents protecteurs rénaux contenant de l'amifostine et des acides aminés

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170818

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9